Citations 2
Efficacy of siltuximab in patients with previously treated multicentric Castleman’s disease (MCD).
Munshi, Nikhil C. , Ke, Xiaoyan , Simpson, David , Lechowicz, Mary Jo , Bandekar, Rajesh, Qin, Xiang , Qi, Ming , Vermeulen, Jessica, Rhee, Frits van , Wong, Raymond , Fosså, Alexander , Dispenzieri, Angela , Kuruvilla, John , Vermeulen, Jessica, Casper, Corey
Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 8514-8514
Randomized, open-label, phase 3 study of subcutaneous daratumumab (DARA SC) versus active monitoring in patients (Pts) with high-risk smoldering multiple myeloma (SMM): AQUILA.
Voorhees, Peter M. , Goldschmidt, Hartmut , Bandekar, Rajesh, Kuppens, Steven, Qi, Ming , Rajkumar, S. Vincent , Baker, Ross , Neff, Tobias , Dimopoulos, Meletios Α.
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: TPS8062-TPS8062